Company: SNWV
Filing Date: 2025-01-10
Form Type: 8-K
Source: 0001628280-25-001163
Chunk: 1

Company: SANUWAVE Health, Inc.
Filing Date: 2025-01-10
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01 Regulation FD Disclosure

Effective January 6, 2025, the Company appointed Timothy Wern as the Company’s Executive Vice President of Sales. Mr. Wern brings deep experience in sales, team building, and funnel management from a career of progressive leadership roles at pioneering companies in healthcare, including HeartWare International, Inc. (acquired by Medtronic plc), Abiomed, Inc. (acquired by Johnson & Johnson), and Ceevra Inc. His extensive background includes leading high-performing sales teams and successfully launching cutting-edge medical devices in the U. S. and Canadian markets. His expertise spans sales management, strategic planning, and launching transformative technologies that aim to improve patient outcomes.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               SANUWAVE HEALTH, INC.                               
  Dated: January 10, 2025                                                          
                               By:                        /s/ Morgan Frank         
                               Name:                      Morgan Frank             
                               Title:                     Chief Executive Officer